Profound Medical Corp (TSX:PRN, Financial) is set to release its Q4 2024 earnings on March 6, 2025. The consensus estimate for Q4 2024 revenue is $6.15 million, and the earnings are expected to come in at -$0.48 per share. The full year 2024's revenue is expected to be $16.10 million and the earnings are expected to be -$1.70 per share. More detailed estimate data can be found on the Forecast page.
Profound Medical Corp (TSX:PRN, Financial) Estimates Trends
Revenue estimates for Profound Medical Corp (TSX:PRN) have remained steady at $16.10 million for the full year 2024. For 2025, revenue estimates have increased from $39.98 million to $40.46 million over the past 90 days. Earnings estimates for 2024 have improved from -$1.74 per share to -$1.70 per share. Similarly, for 2025, earnings estimates have increased from -$1.39 per share to -$1.26 per share over the past 90 days.
Profound Medical Corp (TSX:PRN, Financial) Reported History
In the previous quarter ending September 30, 2024, Profound Medical Corp's (TSX:PRN) actual revenue was $4.09 million, which missed analysts' revenue expectations of $4.16 million by -1.68%. Profound Medical Corp's (TSX:PRN) actual earnings were -$0.55 per share, which missed analysts' earnings expectations of -$0.42 per share by -29.86%. After releasing the results, Profound Medical Corp (TSX:PRN) was up by 10.27% in one day.
Profound Medical Corp (TSX:PRN, Financial) 12 Month Price Targets
Based on the one-year price targets offered by one analyst, the average target price for Profound Medical Corp (TSX:PRN) is $25.96, with both the high and low estimates at $25.96. The average target implies an upside of 152.08% from the current price of $10.30.
Based on GuruFocus estimates, the estimated GF Value for Profound Medical Corp (TSX:PRN, Financial) in one year is $12.41, suggesting an upside of 20.49% from the current price of $10.30.
Based on the consensus recommendation from two brokerage firms, Profound Medical Corp's (TSX:PRN, Financial) average brokerage recommendation is currently 1.5, indicating a "Buy" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
